Viewing Study NCT06439056

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:35 PM
Ignite Modification Date: 2026-03-29 @ 12:31 PM
Study NCT ID: NCT06439056
Status: COMPLETED
Last Update Posted: 2025-09-23
First Post: 2024-05-16
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Phase 1 Study Assessing the Pharmacokinetics of NEX-22A in Subjects With T2D
Sponsor: Nanexa AB
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Type 2 Diabetes View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Type 2 diabetes View
None PK study View
None Long acting injectable View
None Liraglutid View
None GLP-1 View